Literature DB >> 12744872

Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium).

Marie Van der Wielen1, Pierre Van Damme, Koen Van Herck, Susanna Schlegel-Haueter, Claire-Anne Siegrist.   

Abstract

To determine age-dependent pertussis immune response in the Flemish population, antibody levels to pertactin (PRN), pertussis toxin (PT) and filamentous hemagglutinin (FHA) were measured in serum samples from 1622 healthy 1-100-year-old subjects. For anti-PRN and anti-PT antibodies, peaks in GMTs were seen in infancy and again in the 10-15-year age group. After age of 20 years, anti-PRN GMT declined rapidly over a decade, followed by a slower decline. Anti-FHA GMT tended to rather increase progressively with age. These data confirm waning of vaccine-induced antibody levels and suggest pertussis resurgence during adolescence and young adulthood. These results support a pertussis booster vaccination policy for adolescents and adults.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744872     DOI: 10.1016/s0264-410x(03)00062-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.

Authors:  Maja Socan; Katarina Prosenc; Miljana Vegnuti
Journal:  Wien Klin Wochenschr       Date:  2006-06       Impact factor: 1.704

2.  Incidence of Pertussis in Anbar Province, West of Iraq, during 2009-2019.

Authors:  E Mohammed Abdullah; A M Abdulla; M Ali Khalil; H Ahmed Owaid
Journal:  Arch Razi Inst       Date:  2021-12-30

3.  Seroepidemiology of Bordetella pertussis infections in the twin cities of Pakistan.

Authors:  Muhammad Ali Syed; Fahad Said; S Habib Ali Bukhari
Journal:  N Am J Med Sci       Date:  2009-12

4.  Bordetella pertussis seroprevalence in Belgian adults aged 20-39 years, 2012.

Authors:  K Huygen; C Rodeghiero; D Govaerts; I Leroux-Roels; P Melin; M Reynders; S Van Der Meeren; S Van Den Wijngaert; D Pierard
Journal:  Epidemiol Infect       Date:  2013-09-27       Impact factor: 4.434

5.  A Belgian Serosurveillance/Seroprevalence Study of Diphtheria, Tetanus and Pertussis Using a Luminex xMAP Technology-Based Pentaplex.

Authors:  Raissa Nadège Caboré; Denis Piérard; Kris Huygen
Journal:  Vaccines (Basel)       Date:  2016-05-10

6.  A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses.

Authors:  Takumi Moriuchi; Nao Otsuka; Yukihiro Hiramatsu; Keigo Shibayama; Kazunari Kamachi
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

7.  Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients.

Authors:  Lise Boey; Eline Bosmans; Liane Braz Ferreira; Nathalie Heyvaert; Melissa Nelen; Lisa Smans; Hanne Tuerlinckx; Mathieu Roelants; Kathleen Claes; Inge Derdelinckx; Wim Janssens; Chantal Mathieu; Johan Van Cleemput; Robin Vos; Isabelle Desombere; Corinne Vandermeulen
Journal:  Vaccines (Basel)       Date:  2021-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.